Emma Arriola

585 total citations
9 papers, 465 citations indexed

About

Emma Arriola is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Emma Arriola has authored 9 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Emma Arriola's work include Multiple Myeloma Research and Treatments (3 papers), Cancer-related Molecular Pathways (3 papers) and Protein Degradation and Inhibitors (3 papers). Emma Arriola is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Cancer-related Molecular Pathways (3 papers) and Protein Degradation and Inhibitors (3 papers). Emma Arriola collaborates with scholars based in United Kingdom, United States and Spain. Emma Arriola's co-authors include Christine M. Chresta, John A. Hickman, Doris Steinemann, Brigitte Schlegelberger, Takashi Sonoki, Reiner Siebert, Hui Liu, Martin J.S. Dyer, Philip W. Tucker and Lana Harder and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Oncogene.

In The Last Decade

Emma Arriola

9 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Arriola United Kingdom 7 276 170 81 79 75 9 465
Scott A. Ezell United States 10 339 1.2× 146 0.9× 76 0.9× 121 1.5× 47 0.6× 11 552
Miriam Enos United States 5 300 1.1× 155 0.9× 77 1.0× 39 0.5× 117 1.6× 6 524
Kerstin Maria Kampa-Schittenhelm Germany 12 283 1.0× 171 1.0× 90 1.1× 34 0.4× 155 2.1× 30 516
Guilhem Couderc France 7 198 0.7× 142 0.8× 84 1.0× 58 0.7× 142 1.9× 9 371
Parham Ramezani-Rad United States 9 262 0.9× 105 0.6× 263 3.2× 57 0.7× 124 1.7× 19 615
Marjan Geugien Netherlands 10 415 1.5× 147 0.9× 66 0.8× 69 0.9× 215 2.9× 13 605
Yulei Shen United States 12 327 1.2× 90 0.5× 121 1.5× 132 1.7× 58 0.8× 24 519
Mikara Robati Australia 9 357 1.3× 164 1.0× 162 2.0× 52 0.7× 63 0.8× 11 511
Cristina Largo Spain 9 268 1.0× 91 0.5× 66 0.8× 133 1.7× 119 1.6× 12 481
Gina M. Ney United States 12 273 1.0× 82 0.5× 102 1.3× 34 0.4× 58 0.8× 19 438

Countries citing papers authored by Emma Arriola

Since Specialization
Citations

This map shows the geographic impact of Emma Arriola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Arriola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Arriola more than expected).

Fields of papers citing papers by Emma Arriola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Arriola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Arriola. The network helps show where Emma Arriola may publish in the future.

Co-authorship network of co-authors of Emma Arriola

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Arriola. A scholar is included among the top collaborators of Emma Arriola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Arriola. Emma Arriola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Gasparetto, Cristina, Kristian M. Bowles, Al‐Ola Abdallah, et al.. (2021). A Phase II Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 21(11). 775–784. 13 indexed citations
3.
Mateos, María‐Victoria, Philippe Moreau, Meletios Α. Dimopoulos, et al.. (2020). A phase III, randomized, multicenter, open-label study of venetoclax or pomalidomide in combination with dexamethasone in patients with t(11;14)-positive relapsed/refractory multiple myeloma.. Journal of Clinical Oncology. 38(15_suppl). TPS8554–TPS8554. 13 indexed citations
4.
Tandstad, Torgrim, Aude Fléchon, Jorge Aparicio, et al.. (2015). 2601 Outcome of relapses after adjuvant carboplatin in clinical stage I seminoma. European Journal of Cancer. 51. S511–S512. 1 indexed citations
5.
Satterwhite, Ed, Takashi Sonoki, Tony G. Willis, et al.. (2001). The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood. 98(12). 3413–3420. 242 indexed citations
6.
Arriola, Emma, et al.. (1999). Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop. Oncogene. 18(4). 1081–1091. 52 indexed citations
7.
8.
Chresta, Christine M., Emma Arriola, & John A. Hickman. (1999). Apoptosis and Cancer Chemotherapy. Humana Press eBooks. 232–40. 36 indexed citations
9.
Luna‐Pérez, Pedro, et al.. (1998). p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma. Annals of Surgical Oncology. 5(3). 203–208. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott A. Ezell Breakdown of academic impact, for papers by Miriam Enos Breakdown of academic impact, for papers by Kerstin Maria Kampa-Schittenhelm Breakdown of academic impact, for papers by Guilhem Couderc Breakdown of academic impact, for papers by Parham Ramezani-Rad Breakdown of academic impact, for papers by Marjan Geugien Breakdown of academic impact, for papers by Yulei Shen Breakdown of academic impact, for papers by Mikara Robati Breakdown of academic impact, for papers by Cristina Largo Breakdown of academic impact, for papers by Gina M. Ney
Rankless by CCL
2026